Gabapentin suppresses cortical spreading depression susceptibility

Journal of Cerebral Blood Flow and Metabolism

Volumn 30, Issue 9, 2010, Pages 1588-1592

  Hoffmann, Ulrike ^a   Dileköz, Ergin ^a,b   Kudo, Chiho ^a,c   Ayata, Cenk ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GAZI UNIVERSITY   (Turkey)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

cortex; electrophysiology; gabapentin; rat; spreading depression

Indexed keywords

CALCIUM CHANNEL; GABAPENTIN; POTASSIUM CHLORIDE; 4 AMINOBUTYRIC ACID; AMINE; AMINO ACID RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GLUTAMIC ACID; VOLTAGE-DEPENDENT CALCIUM CHANNEL (P-Q TYPE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BRAIN ELECTROPHYSIOLOGY; BRAIN HEMORRHAGE; CONTROLLED STUDY; DEPOLARIZATION; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPREADING CORTICAL DEPRESSION; STROKE; TRAUMATIC BRAIN INJURY; ANESTHESIA; ANIMAL; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; SPRAGUE DAWLEY RAT;

AMINES; ANESTHESIA; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CORTICAL SPREADING DEPRESSION; CYCLOHEXANECARBOXYLIC ACIDS; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INJECTIONS, INTRAVENOUS; MALE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77956262895     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.92     Document Type: Article

References (16)

1. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz M.A. (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59:652-661
2. Dooley DJ, Taylor CP, Donevan S, Feltner D (2007) Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 28:75-82
3. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271:5768-5776
4. Hashemi P, Bhatia R, Nakamura H, Dreier JP, Graf R, Strong AJ, Boutelle MG (2009) Persisting depletion of brain glucose following cortical spreading depression, despite apparent hyperaemia: evidence for risk of an adverse effect of Leaos spreading depression. J Cereb Blood Flow Metab 29:166-175
5. Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC (2008) Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proc Natl Acad Sci USA 105:3628-3633
6. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ (1997) The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324:153-160
7. Kunkler PE, Kraig RP (2004) P/Q Ca2+ channel blockade stops spreading depression and related pyramidal neuronal Ca2+ rise in hippocampal organ culture. Hippocampus 14:356-367
8. Radulovic LL, Turck D, von Hodenberg A, Vollmer KO, McNally WP, DeHart PD, Hanson BJ, Bockbrader HN, Chang T (1995) Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab Dispos 23:441-448
9. Richter F, Ebersberger A, Schaible HG (2002) Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression. Neurosci Lett 334:123-126
10. Sakowitz OW, Kiening KL, Krajewski KL, Sarrafzadeh AS, Fabricius M, Strong AJ, Unterberg AW, Dreier JP (2009) Preliminary evidence that ketamine inhibits spreading depolarizations in acute human brain injury. Stroke 40:e519-22
11. Shin HK, Dunn AK, Jones PB, Boas DA, Moskowitz M.A., Ayata C (2006) Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab 26:1018-1030
12. Stewart BH, Kugler AR, Thompson PR, Bockbrader HN (1993) A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 10:276-281
13. Strong AJ, Anderson PJ, Watts HR, Virley DJ, Lloyd A, Irving EA, Nagafuji T, Ninomiya M, Nakamura H, Dunn AK, Graf R (2007) Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain 130:995-1008
14. van Hooft JA, Dougherty JJ, Endeman D, Nichols RA, Wadman WJ (2002) Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex. Eur J Pharmacol 449: 221-228
15. Welty DF, Schielke GP, Vartanian MG, Taylor CP (1993) Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res 16:175-181
16. Williams AJ, Bautista CC, Chen RW, Dave JR, Lu XC, Tortella FC, Hartings JA (2006) Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats. J Pharmacol Exp Ther 318:947-955